Icon

STRATTERA (nda021411)- (EQ 5MG BASE,EQ 10MG BASE,EQ 18MG BASE,EQ 25MG BASE,EQ 40MG BASE,EQ 60MG BASE,EQ 80MG BASE,EQ 100MG BASE)

ATOMOXETINE HYDROCHLORIDE LILLY
EQ 5MG BASE,EQ 10MG BASE,EQ 18MG BASE,EQ 25MG BASE,EQ 40MG BASE,EQ 60MG BASE,EQ 80MG BASE,EQ 100MG BASE
Yes No
2017-May-26 Expired
None None
None No
STRATTERA ® is a selective norepinephrine reuptake inhibitor indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD).
8 2 7
Total Other Developers 11
Drugs with Suitability No
EQ 5MG BASE ** ** - - -
EQ 10MG BASE ** ** - - 6
EQ 18MG BASE ** ** - - 6
EQ 25MG BASE ** ** - - 6
EQ 40MG BASE ** ** - - 6
EQ 60MG BASE ** ** - - 6
EQ 80MG BASE ** ** - - 6
EQ 100MG BASE ** ** - - 6
NDA Sales Available Total Generic Sales Available
No 6
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ****** ****** ***. *********** *** ****** *****, *******, ******* *** ***, ****** (***) ***
****** ********* ****** ********* ****** ******* *********** ****-***, **. **.*** & ***, **********, ********** ******, *******-********** ********, *******, ********* ******, ***** (***) ***
****** ******** ****** *** ******** *************** ******* *********** **** ** *-*, ******* ********** ******, *******-******,, ***, ** ******, ***** (***) ***
****** ******** ****** *** ****** **** ******* *** *********** ****** **. **, *.*.*., ************* (*******), ******** (******), **********, ********* ******, ***** (***) ***
****** ** ****** **. *****'* ************ ******* *********** ****** **. **, ** ****, ** **** & ** ****, ********** ******* *** ******, *******-********** ********,, *******-**********, ********* ******, ***** (***) ***
****** ****** **** *** * ****** ****** ******* ******* *********** ****** **. ***, ******* *******, *********** ******,, **********, ********* ******, ***** (***) ***
****** ***** ****** *** *** ***** ************ ******* *********** ****** **. ***, *** & ***, ******* ***** ******** ******* ** * *, *******-*******, ***-******, ****. - *********, *********, ******* ******, ***** (***) ***
****** **** ****** *** ***** ******** *.*.*. *********** ****** ****** ********** **, ******, *****, ******* (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.